Establishment of novel PDXovo models for neuroendocrine neoplasms
Iacovos Michael, PhD
Finished Projects
Evaluation of Ac-225 dotatate for treatment of lung carcinoid tumors
David Morse, PhD
Ex vivo compound prioritization for gastroenteropancreatic NETs
Andrea Califano, PhD
Exploring the role of epigenetic dysregulation in PanNET progression
Sita Kugel, PhD
Fluorine-18 labeled MIBG analogues for theranostic applications
David Raffel, PhD
Functionalized silica nanoparticles: development of a combined PET and TAT theranostic agent for NETs
Tara Mastren, PhD
Generate mouse models of neuroendocrine cancer
Seung Kim, MD, PhD
Generation and characterization of a novel genetically modified patient–derived NET organoid system
James Yao, MD
Hypoxia Onco-metabolic Drivers in Pancreatic and Small Intestine NET
Amit Tirosh, MD
Identify and validate molecular targets for therapy in a newly developed human midgut carcinoid tumor cell line
Lee Ellis, MD